Hemo Organic Limited (BOM:524590)
21.85
0.00 (0.00%)
At close: Oct 26, 2026
Hemo Organic Revenue
Hemo Organic had revenue of 14.29M INR in the quarter ending September 30, 2026, with 1,428,900.00% growth. This brings the company's total for the last twelve months to 23.58M, down -5.16% year-over-year. In the fiscal year ending March 31, 2026, Hemo Organic had annual revenue of 9.31M, down -62.52%. That makes Hemo Organic the 45,264th largest company in the world by revenue and 4,867th in India.
Revenue (ttm)
23.58M
Revenue Growth
-5.16%
P/S Ratio
3.21
Revenue / Employee
4.72M
Employees
5
Market Cap
75.73M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2026 | 9.31M | -15.53M | -62.52% |
| Mar 31, 2025 | 24.84M | 24.62M | 10,892.04% |
| Mar 31, 2024 | 226.00K | 178.00K | 370.83% |
| Mar 31, 2023 | 48.00K | -20.30K | -29.72% |
| Mar 31, 2022 | 68.30K | -12.40K | -15.37% |
| Mar 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Peeti Securities | 224.45M |
| Brawn Biotech | 172.59M |
| Ganon Products | 79.22M |
| Chd Chemicals | 58.86M |
| Devine Impex | 18.68M |
| ISF Limited | 12.26M |
| Rich Universe Network | 7.49M |
| Sparc Electrex | 6.35M |